• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

IntriCon Corp.

IntriCon closes $95m offering

August 21, 2018 By Fink Densford

IntriCon (NSDQ:IIN) said late yesterday it closed a $94.9 million round of financing slated to support capital expenditures and the repurchasing of company shares. The Arden Hills, Minn.-based company said it sold 1.5 million shares of common stock at $55 per share. The offering also included a fully exercised 30-day underwriter’s option to purchase an additional […]

Filed Under: Business/Financial News, Funding Roundup, Wall Street Beat Tagged With: IntriCon Corp.

IntriCon prices $83m offering

August 16, 2018 By Fink Densford

IntriCon (NSDQ:IIN) today priced an upcoming public offering looking to raise approximately $82.5 million. The Arden Hills, Minn.-based company said it is looking to float 1.5 million shares of common stock at $55 per share, and that the offering is expected to close on August 20. The offering includes a 30-day underwriter’s option to purchase an […]

Filed Under: Business/Financial News, Wall Street Beat Tagged With: IntriCon Corp.

7 medtech stories we missed this week: March 16, 2018

March 16, 2018 By Danielle Kirsh

From Intricon expanding its manufacturing space to Arthrex signing a global distribution deal, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Intricon expands medical footprint Intricon announced in a March 13 press release that it has signed a 5-year lease that will secure 30,000 sq. ft of manufacturing […]

Filed Under: 510(k), Contract Manufacturing, Diagnostics, Hospital Care, Imaging, Orthopedics, Patient Monitoring, Regulatory/Compliance, Software / IT, Spine Tagged With: Arch Therapeutics, Arthrex Inc., CellRight Technologies, Enhatch, Guided Therapeutics Inc., IntriCon Corp., Life Spine Inc., unitedhealthproducts

IntriCon slips on missed Q2 prelims

July 1, 2016 By Fink Densford

IntriCon (NSDQ:IIN) saw shares fall over 9% after releasing preliminary 2nd quarter earnings that are off the mark, well under Street analysts expectations. The Arden Hills, Minn.-based company said it expects losses of approximately $1.4 million, or 19-22¢ per share, on sales of $16.8 million for the 3 months ended June 30. That amounts to a significant […]

Filed Under: Business/Financial News Tagged With: IntriCon Corp.

IntriCon acquires hearing aid company PC Werth

November 6, 2015 By Fink Densford

Intricon (NSDQ:IIN) said Tuesday it bought the assets ofhearing healthcare product manufacturer PC Werth, a leading hearing aid supplier to the U.K.’s National Health Service. Intricon said it inked an exclusive agreement with PC Werth last December to distribute its hearing aid products in the U.K., but the full acquisition will allow Intricon extra access […]

Filed Under: Business/Financial News, Mergers & Acquisitions, Otolaryngology/Ear, Nose & Throat (ENT) Tagged With: IntriCon Corp.

Medtronic provides the lone bright spot for IntriCon’s Q2

August 7, 2015 By Brad Perriello

IntriCon (NSDQ:IIN) this week said that its 2nd-quarter sales and earnings were off, except for an 8% increase in its medical business revenues largely credited to Medtronic (NYSE:MDT), the body-worn sensor company’s largest customer. Arden Hills, Minn.-based IntriCon posted profits of $506,000, or 8¢ per share, on sales of $17.1 million for the 3 months ended […]

Filed Under: Diabetes, MassDevice Earnings Roundup Tagged With: IntriCon Corp., Medtronic

Layoffs: IntriCon’s undergoes “right-sizing” by firing 35 admin and support workers

June 17, 2013 By Arezu Sarvestani Leave a Comment

IntriCon logo

Minnesota medical monitoring devices maker IntriCon Corp. told investors this month that the company plans to cut about 6% of its workforce as part of a larger restructuring effort to lower costs and focus on business areas with the highest growth potential.

IntriCon announced that it would lay off 35 "administrative and support employees," a move that will immediately save the company $2 million per year. Most of the cuts will be immediate, but layoffs in Maine will undergo a "phased" approach, the company added.

Filed Under: News Well, Patient Monitoring Tagged With: IntriCon Corp., Layoffs, Remote Patient Monitoring

Diabetes: Medtronic wins clearance for next-gen clinical continuous glucose monitor | Regulatory Roundup

November 25, 2011 By MassDevice staff Leave a Comment

Medtronic logo

Medtronic Inc. (NYSE:MDT) won FDA clearance for its next generation iPro2 Professional continuous glucose monitor.

The iPro2 Professional is a clinician-owned device that collects glucose data from a sensor inserted into a patient’s skin.

The device tracks the patient’s glucose levels for 3 days, collecting data as many as 288 times each day. The information may provide insight into how diet, medication and daily activities affect a patient’s glucose levels.

Filed Under: News Well Tagged With: BSD Medical Corp., Canon, CerMed International, Clinical Trials, Dendreon Corp., Fujifilm, IntriCon Corp., IsoRay, Merz, neovasc, Regulatory Roundup, Retina Implant AG, STAAR Surgical Co, Translational Sciences Corp., Vascular Designs Inc.

Accuray dives despite beating The Street as losses gape | Earnings Roundup

November 9, 2011 By MassDevice staff Leave a Comment

Accuray

Accuray (NSDQ:ARAY) shares are down today after the radiosurgery company reported surging first-quarter sales and beat Wall Street’s earnings expectations, as investors reacted to net losses of nearly six times the Q1 2011 mark.

Accuray reported losses of $26.5 million, or 38 cents per share, on sales of $100.5 million for the three months ended Sept. 30. That’s top-line growth of 163.9 percent compared with the same period last year, largely due to the massive infusion that followed ARAY’s acquisition of rival TomoTherapy earlier this year.

Filed Under: MassDevice Earnings Roundup, News Well, Radiosurgery/Radiation therapy Tagged With: Accuray Inc., Bioject Medical Technologies Inc., BioMimetic Therapeutics Inc., CardioNet Inc., CAS Medical Systems Inc., Cutera Inc., Echo Therapeutics Inc., Electromed, IntriCon Corp., Kips Bay Medical Inc., Misonix, Nobel Biocare Holdings AG, Pro-Dex Inc., Q3, Tornier Inc.

Covidien lands $1.5 billion credit facility | Deals roundup

August 16, 2011 By MassDevice staff Leave a Comment

Covidien

Covidien Plc. (NYSE:COV) announced a new agreement for a five year $1.5 billion senior unsecured revolving credit facility, secured through subsidiary Covidien International Finance S.A.

The new agreement replaces a prior five-year senior credit facility that was slated to mature in April 2012, and the funds will be allocated for general corporate purposes, including working capital and capital expenditures.

Filed Under: Funding Roundup, Mergers & Acquisitions, News Well, Wall Street Beat Tagged With: Covidien, Deals Roundup, Devicor Medical Products, Fluidnet Corp., Hatch Medical LLC, Hospital for Special Surgery, Immucor Inc., Innovative Orthopaedic Devices Inc., IntriCon Corp., Loquendo, Navidea Biopharmaceuticals, Nuance Communications Inc., Nuvasive, pSivida Corp., ReGear Life Sciences Inc., sironrx, transmedics

Echo Therapeutics posts a tough quarter | Earnings Roundup

August 12, 2011 By MassDevice staff Leave a Comment

Echo Therapeutics

 Echo Therapeutics Inc.’s (OTC:ECTE) grew more than three fold in Q2 as the company poured money into research & development and administrative expenses.

Losses for the quarter widened 262 percent to $1.9 million, or a loss of 6 cents per diluted share, during the three months ended June 30, compared to losses of $536,000, or 2 cents lost per diluted share, during the same period last year.

Filed Under: MassDevice Earnings Roundup, News Well, Wall Street Beat Tagged With: Baxano Surgical, Bioject Medical Technologies Inc., Bovie Medical Corp., dextera, Echo Therapeutics Inc., IntriCon Corp., InVivo Therapeutics, Q2, Thergenics Corp., Tiger X Medical Inc., Tornier Inc., Vision Sciences Inc., World Heart Corp.

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

May 27, 2022
Quick message - No DTW podcast, but plenty else to listen to over this weekend and next week.
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS